Top

Current Breast Cancer Reports

Published in:

01-12-2019 | Breast Cancer | Global Breast Cancer (AB Chagpar, Section Editor)

Report from the Front: a Glimpse at Breast Cancer Research in Low- and Middle-Income Countries

Authors: Evangelia Razis, James Balogun, Manjola Lushi, Khalid Abdel Karim, Despoina Kalapanida, Webster Kadzatsa

Published in: Current Breast Cancer Reports | Issue 4/2019

Abstract

Purpose of Review

Breast cancer is increasingly more prevalent in low- and middle-income countries (LMICs) and its biology in these populations may differ from that in more affluent countries. Research in these settings is limited by both societal factors and the lack of resources. Our intent is to review the parameters that limit more extensive research activities in LMICs and potentially investigate options for improvement.

Findings

LMIC governments have limited infrastructure to support appropriate research and the physicians are overburdened by clinical work. Even the patients fail to see the value of research in some countries. Funding and support from pharmaceutical companies is usually channeled to higher income countries with advanced infrastructure.

Summary

Recent research demonstrates the multi-faceted problems with the conduct of clinical studies in LMICs. A concerted effort by the state and physicians can lead to the development of conditions conducive to research. Such efforts are of paramount importance as the potential of research activities in LMICs is very significant and capacity building can bring in funding, new medications, and ultimately better care for breast cancer patients in LMICs.

DeSantis CE, Bray F, Ferlay J, et al. International variation in female breast cancer incidence and mortality rates. Cancer Epidemiol Biomark Prev. 2015;24(10):1495–506. https://doi.org/10.1158/1055-9965.EPI-15-0535.CrossRef

Martei YM, Pace LE, Brock JE, Shulman LN. Breast cancer in low- and middle-income countries: why we need pathology capability to solve this challenge. Clin Lab Med. 2018;38(1):161–73. https://doi.org/10.1016/j.cll.2017.10.013.CrossRefPubMed

McKee M, Stuckler D, Basu S. Where there is no health research: what can be done to fill the global gaps in health research? PLoS Med. 2012;9(4):e1001209. Published online 2012 Apr 24. https://doi.org/10.1371/journal.pmed.1001209.CrossRefPubMedPubMedCentral

Jacobsen KH. Patterns of co-authorship in international epidemiology. J Epidemiol Community Health. 2009;63(8):665–9. https://doi.org/10.1136/jech.2008.082883.CrossRefPubMed

Birnbaum JK, Duggan C, Anderson BO, Etzioni R. Early detection and treatment strategies for breast cancer in low-income and upper middle-income countries: a modeling study. Lancet Glob Health. 2018;6(8):e885–93. https://doi.org/10.1016/S2214-109X(18)30257-2.CrossRefPubMedPubMedCentral

•• Lynch-Kelly K, Singer M, Williams NR. The landscape of randomised controlled trials of therapies in breast cancer in low and middle income countries. Int J Breast Cancer. 2017;2017:4259704. https://doi.org/10.1155/2017/4259704. This study describes the current situation in full! Only 69 of over 1000 breast cancer studies were active in LMICs. CrossRefPubMedPubMedCentral

Harford J, Azavedo E, Fischietto M, Breast Health Global Initiative Healthcare Systems Panel. Guideline implementation for breast healthcare in low- and middle-income countries: breast healthcare program resource allocation. Cancer. 2008;113(8 Suppl):2282–96. https://doi.org/10.1002/cncr.23841.CrossRefPubMed

Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–917. https://doi.org/10.1002/ijc.25516.CrossRefPubMed

Anderson BO, Ilbawi AM, El Saghir NS. Breast cancer in low and middle income countries (LMICs): a shifting tide in global health. Breast J. 2015;21(1):111–8. https://doi.org/10.1111/tbj.12357.CrossRefPubMed

10.

• Fischer SE, Alatise OI, Komolafe AO, et al. Establishing a cancer research consortium in low- and middle-income countries: challenges faced and lessons learned. Ann Surg Oncol. 2017;24(3):627–31. https://doi.org/10.1245/s10434-016-5624-2. This report indicates what could be done to improve the status of research in a LMIC by drawing on the example of a Nigerian consortium. CrossRefPubMed

11.

Rivera-Franco MM, Leon-Rodriguez E. Delays in breast cancer detection and treatment in developing countries [published correction appears in Breast Cancer (Auckl). 2019 Mar 11;13:1178223419834790]. Breast Cancer (Auckl). 2018;12. Published 2018 Jan 8. https://doi.org/10.1177/1178223417752677.

12.

McGregor S, Henderson KJ, Kaldor JM. How are health research priorities set in low and middle income countries? A systematic review of published reports. PLoS One. 2014;9(10):e108787. Published online 2014 Oct 2. https://doi.org/10.1371/journal.pone.0108787.CrossRefPubMedPubMedCentral

13.

Glickman SW, McHutchison JG, Peterson ED, Cairns CB, Harrington RA, Califf RM, et al. Ethical and scientific implications of the globalization of clinical research. N Engl J Med. 2009;360:816–23.CrossRef

14.

Castro-Leal VF, Dayton J, Demery L, Mehra K. Public spending on health care in Africa: do the poor benefit? Bull World Health Organ. 2000;78(1):66–74.PubMedPubMedCentral

15.

• Simpkin V, Namubiru-Mwaura E, Clarke L, Mossialos E. Investing in health R&D: where we are, what limits us, and how to make progress in Africa. BMJ Glob Health. 2019;4(2):e001047 This study reveals the improvement. This study demonstrates the issues and potential for funding research and development in Africa. CrossRef

16.

Lansang MA, Dennis R. Building capacity in health research in the developing world. Bull World Health Organ. 2004;82(10):764–70.PubMedPubMedCentral

17.

• Sam-Agudu NA, Paintsil E, Aliyu MH, et al. Building sustainable local capacity for global health research in West Africa. Ann Glob Health. 2016;82(6):1010–25. This study presents the educational needs to develop researchers in LMICs. CrossRef

18.

Tangka FK, Subramanian S, Edwards P, Cole-Beebe M, Parkin DM, Bray F, et al. Resource requirements for cancer registration in areas with limited resources: analysis of cost data from four low- and middle-income countries. Cancer Epidemiol. 2016;45(Suppl 1):S50–8. Published online 2016 Oct 25. https://doi.org/10.1016/j.canep.2016.10.009.CrossRefPubMedPubMedCentral

19.

Jedy-Agba EE, Oga EA, Odutola M, Abdullahi YM, Popoola A, Achara P, et al. Developing national cancer registration in developing countries – case study of the Nigerian National System of Cancer registries. Front Public Health. 2015;3:186. Published online 2015 Jul 30. https://doi.org/10.3389/fpubh.2015.00186.CrossRefPubMedPubMedCentral

20.

Ly M, Antoine M, Dembélé AK, Levy P, Rodenas A, Touré BA, et al. High incidence of triple-negative tumors in sub-Saharan Africa: a prospective study of breast cancer characteristics and risk factors in Malian women seen in a Bamako university hospital. Oncology. 2012;83(5):257–63. https://doi.org/10.1159/000341541.CrossRefPubMed

21.

• Nyante SJ, Biritwum R, Figueroa J, et al. Recruiting population controls for case-control studies in sub-Saharan Africa: the Ghana Breast Health Study. PLoS One. 2019;14(4):e0215347. https://doi.org/10.1371/journal.pone.0215347 eCollection 2019. This report shows how patients can be motivated to participate in research and contribute to registries. CrossRefPubMedPubMedCentral

22.

Carmen MG, Herman J, Rao S, et al. Trends and factors associated with physician burnout at a multispecialty academic faculty practice organization. JAMA Netw Open. 2019;2(3):e190554. https://doi.org/10.1001/jamanetworkopen.2019.0554.CrossRefPubMedPubMedCentral

23.

Cowie MR, Blomster JI, Curtis LH, Duclaux S, Ford I, Fritz F, et al. Electronic health records to facilitate clinical research. Clin Res Cardiol. 2017;106(1):1–9.CrossRef

24.

Clay S. Ego is the enemy [Internet]. JournalFeed. [cited 2019 Apr 30]. Available from: https://journalfeed.org/article-a-day/2018/ego-is-the-enemy.

25.

Dong J, Mirza Z. Supporting the production of pharmaceuticals in Africa. Bull World Health Organ. 2016;94(1):71–2.CrossRef

26.

Rabiu TB, Balogun JA. Repositioning health research in developing countries. Arch Med Res. 2009;40(3):223. https://doi.org/10.1016/j.arcmed.2009.02.001.CrossRefPubMed

27.

Adedokun BO, Olopade CO, Olopade OI. Building local capacity for genomics research in Africa: recommendations from analysis of publications in Sub-Saharan Africa from 2004 to 2013. Glob Health Action. 2016;9:31026. https://doi.org/10.3402/gha.v9.31026 eCollection 2016.CrossRefPubMed

28.

Van Noorden R. Open access: the true cost of science publishing. Nature. 2013;495(7442):426–9. https://doi.org/10.1038/495426a.CrossRefPubMed

29.

Dhalla KA, Guirguis M. Barriers and incentives for conducting research amongst the ophthalmologists in Sub-Sahara Africa. PLoS One. 2018;13(10):e0197945. Published online 2018 Oct 23. https://doi.org/10.1371/journal.pone.0197945.CrossRefPubMedPubMedCentral

30.

Y.W. Joko-Fru, L.Haemmerl, M.Griesel, et al. Breast Cancer Treatment in Sub-Saharan Africa: A Population-Based Registry Study. J Glob Oncol 2018 4:Supplement 3, 20s-20s CrossRef

31.

Khullar D, Blumenthal DM, Olenski AR, Jena AB. U.S. immigration policy and American medical research: the scientific contributions of foreign medical graduates. Ann Intern Med. 2017;167(8):584–6. https://doi.org/10.7326/M17-1304.CrossRefPubMed

32.

Ogunbiyi JO, Stefan DC, Rebbeck TR. African Organization for Research and Training in Cancer: position and vision for cancer research on the African continent. Infect Agents Cancer. 2016;11:63 eCollection 2016.CrossRef

33.

• Gopal S. Cancer trials in sub-Saharan Africa: aligning research and care. PLoS Med. 2017;14(7):e1002351. https://doi.org/10.1371/journal.pmed.1002351 eCollection 2017 Jul. A review of how research can be integrated in healthcare in LMICs. CrossRef

34.

Harford JB. Barriers to overcome for effective cancer control in Africa. Lancet Oncol. 2015;16(8):e385–93. https://doi.org/10.1016/S1470-2045(15)00160-6.CrossRefPubMed

35.

Shehata SM, ElMashad NM, Hassan AM. Current review of medical research in developing countries: a case study from Egypt 2017 https://doi.org/10.5772/67282.

36.

Alemayehu C, Mitchell G, Nikles J. Barriers for conducting clinical trials in developing countries- a systematic review. Int J Equity Health. 2018;17(1):37. Published 2018 Mar 22. https://doi.org/10.1186/s12939-018-0748-6.CrossRefPubMedPubMedCentral

37.

Meacham E, Orem J, Nakigudde G, Zujewski JA, Rao D. Exploring stigma as a barrier to cancer service engagement with breast cancer survivors in Kampala, Uganda. Psycho-Oncology. 2016;25:1206–11. https://doi.org/10.1002/pon.4215.CrossRefPubMed

38.

Kraja J. Patient and public involvement in Albania. ResearchGate; 2019. Available at: https://www.researchgate.net/publication/332780826_Patient_and_Public_Involvement_in_Albania.

39.

Patra SK. Africa hosts very few clinical trials. Why this is bad for innovation. The Conversation. [cited 2019 Apr 30]. Available from: http://theconversation.com/africa-hosts-very-few-clinical-trials-why-this-is-bad-for-innovation-97390.

40.

Anderson BO, Cazap E, El Saghir NS, et al. Optimization of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010. Lancet Oncol. 2011;12(4):387–98. https://doi.org/10.1016/S1470-2045(11)70031-6.CrossRefPubMed

41.

Pace LE, Shulman LN. Breast Cancer in sub-Saharan Africa: challenges and opportunities to reduce mortality. Oncologist. 2016;21(6):739–44. https://doi.org/10.1634/theoncologist.2015-0429.CrossRefPubMedPubMedCentral

42.

• Denburg A, Rodriguez-Galindo C, Joffe S. Clinical trials infrastructure as a quality improvement intervention in low- and middle-income countries. Am J Bioeth. 2016;16(6):3–11. https://doi.org/10.1080/15265161.2016.1170230. A paper introducing the quality in care advantages of clinical trials.CrossRefPubMed

43.

Anderson B, Ballieu M, Bradley C, et al. Access to cancer treatment in low- and middle-income countries – an essential part of global cancer control. Working Paper Can Treat Int, 23 Pages Posted: 28 May 2012.

44.

Kostelecky B, Trimble EL, Bhatia K. Learning lessons from cancer centers in low- and middle-income countries. Infect Agent Cancer. 2013;8(1):44. https://doi.org/10.1186/1750-9378-8-44.CrossRefPubMedPubMedCentral

Title: Report from the Front: a Glimpse at Breast Cancer Research in Low- and Middle-Income Countries
Authors: Evangelia Razis
James Balogun
Manjola Lushi
Khalid Abdel Karim
Despoina Kalapanida
Webster Kadzatsa
Publication date: 01-12-2019
Publisher: Springer US
Keywords: Breast Cancer
Breast Cancer
Published in: Current Breast Cancer Reports / Issue 4/2019
Print ISSN: 1943-4588
Electronic ISSN: 1943-4596
DOI: https://doi.org/10.1007/s12609-019-00329-z

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose of Review

Findings

Summary

Please log in to get access to this content

Other articles of this Issue 4/2019

Immunotherapy in Triple-Negative Breast Cancer: Present and Future

Hot Topic: Should all Women with Breast Cancer Undergo Genetic Testing?

Combination Immunotherapy Strategies in Breast Cancer

Inflammatory Breast Cancer: Diagnostic, Molecular and Therapeutic Considerations

Gut Microbiome and Breast Cancer in the Era of Cancer Immunotherapy

Updates in Genetic Testing Guidelines for Breast Cancer Susceptibility Genes: a Change in the Paradigm

Keynote webinar | Spotlight on antibody–drug conjugates in cancer